Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
3(27%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
1
9%
Ph not_applicable
10
91%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution11 total trials
Phase 1Safety & dosage
1(9.1%)
N/ANon-phased studies
10(90.9%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

3

trials recruiting

Total Trials

11

all time

Status Distribution
Active(3)
Completed(4)
Terminated(1)
Other(3)

Detailed Status

Completed4
unknown3
Active, not recruiting2
Recruiting1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
3
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Phase 11 (9.1%)
N/A10 (90.9%)

Trials by Status

recruiting19%
completed436%
withdrawn19%
active_not_recruiting218%
unknown327%

Recent Activity

Clinical Trials (11)

Showing 11 of 11 trials

All 11 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
11